Indeed, a previous transcriptomic meta-analysis of PD and major depressive disorder (MDD), which is often found in patients with prodromal PD and 3–6 years before development of PD motor symptoms66, also highlighted PATL2 as a potential whole blood biomarker67. The gene discussed is PATL2; the disease is Parkinson disease.